American Century Companies Inc Iovance Biotherapeutics, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 198,674 shares of IOVA stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

198,674

Previous 203,038 2.15%

Holding current value

$1.62 Million

Previous $1.63 Million 14.56%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$7.28 - $11.9 $31,769 - $51,931	-4,364 Reduced 2.15%	198,674 $1.87 Million
Q2 2024 Aug 07, 2024	SELL	$7.78 - $14.19 $1.05 Million - $1.92 Million	-135,478 Reduced 40.02%	203,038 $1.63 Million
Q1 2024 May 14, 2024	BUY	$7.59 - $17.47 $40,834 - $93,988	5,380 Added 1.61%	338,516 $5.02 Million
Q4 2023 Feb 13, 2024	BUY	$3.3 - $8.89 $1.1 Million - $2.96 Million	333,136 New	333,136 $2.71 Million
Q3 2023 Nov 13, 2023	SELL	$4.44 - $8.79 $37,327 - $73,897	-8,407 Reduced 2.02%	408,758 $1.86 Million
Q2 2023 Aug 14, 2023	BUY	$5.36 - $9.06 $524,502 - $886,566	97,855 Added 30.65%	417,165 $2.94 Million
Q1 2023 May 11, 2023	BUY	$5.53 - $8.22 $9,118 - $13,554	1,649 Added 0.52%	319,310 $1.95 Million
Q4 2022 Feb 13, 2023	SELL	$5.62 - $10.0 $859,449 - $1.53 Million	-152,927 Reduced 32.5%	317,661 $2.03 Million
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $52,453 - $72,157	5,504 Added 1.18%	470,588 $4.51 Million
Q2 2022 Aug 12, 2022	BUY	$6.38 - $18.33 $358,517 - $1.03 Million	56,194 Added 13.74%	465,084 $5.13 Million
Q1 2022 May 11, 2022	BUY	$12.38 - $19.1 $4,419 - $6,818	357 Added 0.09%	408,890 $6.81 Million
Q4 2021 Feb 07, 2022	BUY	$16.55 - $27.63 $519,322 - $867,001	31,379 Added 8.32%	408,533 $7.8 Million
Q3 2021 Nov 10, 2021	BUY	$20.35 - $26.63 $1,322 - $1,730	65 Added 0.02%	377,154 $9.3 Million
Q2 2021 Aug 05, 2021	BUY	$16.33 - $33.07 $123,454 - $250,009	7,560 Added 2.05%	377,089 $9.81 Million
Q1 2021 May 14, 2021	BUY	$28.67 - $52.59 $692,122 - $1.27 Million	24,141 Added 6.99%	369,529 $11.7 Million
Q4 2020 Feb 12, 2021	BUY	$28.04 - $50.26 $6.11 Million - $11 Million	218,004 Added 171.14%	345,388 $16 Million
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $866,688 - $1.13 Million	-31,232 Reduced 19.69%	127,384 $4.19 Million
Q2 2020 Aug 13, 2020	SELL	$27.21 - $41.0 $4.25 Million - $6.41 Million	-156,340 Reduced 49.64%	158,616 $4.35 Million
Q1 2020 May 14, 2020	BUY	$19.54 - $38.85 $330,460 - $657,031	16,912 Added 5.67%	314,956 $9.43 Million
Q4 2019 Feb 12, 2020	BUY	$17.95 - $29.41 $1.86 Million - $3.04 Million	103,500 Added 53.2%	298,044 $8.25 Million
Q3 2019 Nov 13, 2019	BUY	$17.99 - $26.0 $3.5 Million - $5.06 Million	194,544 New	194,544 $3.54 Million

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Iovance Biotherapeutics, Inc. Transaction History